Re: For what it’s worth

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: For what it’s worth

in response to

Re: For what it’s worth

tada

posted on Jul 20, 2023 06:52AM

tada, but ZEN 3694 is not collaborating with another Big Pharma drug. That is what I meant to convey by the term stand-alone.

ZEN-3694 is kicking and screaming IPO on NASDAQ, right out of the gate !!!

Koo

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply